CAPRICOR THERAPEUTICS, INC. (CAPR) Operating income 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual operating income history from SEC filings — each fiscal year as reported.
-$108.1MFY2025 · since FY2016: -$17.0M → -$108.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$108.1M | -154.1% |
| FY2024 | -$42.6M | -76.8% |
| FY2023 | -$24.1M | +18.9% |
| FY2022 | -$29.7M | -41.8% |
| FY2021 | -$20.9M | -52.9% |
| FY2020 | -$13.7M | -77.0% |
| FY2019 | -$7.7M | +49.5% |
| FY2018 | -$15.3M | -19.2% |
| FY2017 | -$12.9M | +24.2% |
| FY2016 | -$17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice